REQUEST A DEMO
Total
USD $0.00
Search more companies

Jc Oncologia S.A.S (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Other Schools and Instruction | Other Ambulatory Health Care Services
Full name: Jc Oncologia S.A.S Profile Updated: July 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Jc Oncologia S.A.S is a company in Colombia, with a head office in Medellin. It operates in the Ambulatory Health Care Services sector. The enterprise was incorporated on January 19, 2024. There are currently 1 (2026) people employed by Jc Oncologia S.A.S. The company’s latest financial report indicates a net sales revenue increase of 19.54% in 2025. Its’ total assets recorded a growth of 114.11%. The net profit margin of Jc Oncologia S.A.S decreased by 2.95% in 2025.

Headquarters
Calle 40 # 63 C - 52 Apartamento 1103
Medellin; Antioquia;

Contact Details: Purchase the Jc Oncologia S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Jc Oncologia S.A.S report to view the information.
Financial Auditors:
Purchase the Jc Oncologia S.A.S report to view the information.
Incorporation Date:
January 19, 2024
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Jc Oncologia S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
19.54%
Total Operating Revenue
19.54%
Operating Profit
15.16%
Net Profit/Loss for the Period
15.41%
Total Assets
114.11%
Total Equity
115.22%
Operating Profit Margin
-3.39%
Net Profit Margin
-2.95%
Return on Equity (ROE)
-46.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?